Maximus Q3 revenue falls to $1.28 billion; FY26 earnings guidance updated
Maximus reported fiscal third-quarter 2026 revenue of $1.28 billion, down from $1.35 billion a year earlier, while diluted EPS rose to $1.95 from $1.86. The company reiterated its fiscal 2026 revenue guidance of $5.2 billion to $5.35 billion but updated its earnings and free cash flow guidance to reflect a temporary contractual modification on a major federal program, which affects profitability for the rest of the year.
Key points
- Q3 revenue was $1.28 billion versus $1.35 billion a year earlier; prior-year results included natural disaster and clinical volume surges.
- Diluted EPS was $1.95 versus $1.86; adjusted diluted EPS was $2.22 versus $2.16.
- Fiscal 2026 adjusted diluted EPS guidance is now $7.90 to $8.20; free cash flow guidance is $425 million to $475 million.
- Board refreshed the repurchase authorization to $400 million in May 2026; the quarterly dividend is $0.33, payable August 31, 2026.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:38 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.